Skip to Content


In the US, Kytril (granisetron systemic) is a member of the drug class 5HT3 receptor antagonists and is used to treat Nausea/Vomiting - Chemotherapy Induced, Nausea/Vomiting - Postoperative and Nausea/Vomiting - Radiation Induced.

US matches:

UK matches:

Ingredient matches for Kytril


Granisetron is reported as an ingredient of Kytril in the following countries:

  • Brazil
  • Egypt
  • Lebanon
  • Philippines

Granisetron hydrochloride (a derivative of Granisetron) is reported as an ingredient of Kytril in the following countries:

  • Armenia
  • Austria
  • Belgium
  • Bosnia & Herzegowina
  • Brazil
  • Bulgaria
  • Chile
  • China
  • Croatia (Hrvatska)
  • Czech Republic
  • Ecuador
  • Estonia
  • Finland
  • France
  • Greece
  • Hong Kong
  • Indonesia
  • Ireland
  • Italy
  • Japan
  • Lithuania
  • Mexico
  • Netherlands
  • Oman
  • Peru
  • Portugal
  • Serbia
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Taiwan
  • Turkey
  • United Kingdom
  • Uruguay

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.